CHITI, ARTURO
 Distribuzione geografica
Continente #
AS - Asia 3.980
NA - Nord America 2.343
EU - Europa 1.562
SA - Sud America 826
AF - Africa 95
OC - Oceania 34
Totale 8.840
Nazione #
US - Stati Uniti d'America 2.180
SG - Singapore 1.877
CN - Cina 1.092
BR - Brasile 712
IT - Italia 674
HK - Hong Kong 542
RU - Federazione Russa 171
DE - Germania 160
VN - Vietnam 158
GB - Regno Unito 106
FI - Finlandia 83
CA - Canada 81
IN - India 75
NL - Olanda 73
SE - Svezia 70
MX - Messico 67
AT - Austria 53
ES - Italia 53
JP - Giappone 49
AR - Argentina 43
PL - Polonia 37
ZA - Sudafrica 37
AU - Australia 33
BD - Bangladesh 28
TR - Turchia 26
FR - Francia 24
MA - Marocco 23
EC - Ecuador 20
LT - Lituania 20
PK - Pakistan 17
ID - Indonesia 16
IQ - Iraq 14
CO - Colombia 12
PY - Paraguay 12
TH - Thailandia 11
EG - Egitto 10
SA - Arabia Saudita 10
DZ - Algeria 9
CL - Cile 8
IL - Israele 8
UZ - Uzbekistan 8
UA - Ucraina 7
BE - Belgio 6
MY - Malesia 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
JO - Giordania 5
KE - Kenya 5
PE - Perù 5
BO - Bolivia 4
HN - Honduras 4
KR - Corea 4
SK - Slovacchia (Repubblica Slovacca) 4
TN - Tunisia 4
TW - Taiwan 4
UY - Uruguay 4
GE - Georgia 3
HR - Croazia 3
JM - Giamaica 3
OM - Oman 3
BG - Bulgaria 2
BH - Bahrain 2
CG - Congo 2
DM - Dominica 2
GR - Grecia 2
IE - Irlanda 2
IR - Iran 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NP - Nepal 2
PH - Filippine 2
PT - Portogallo 2
RO - Romania 2
SN - Senegal 2
SY - Repubblica araba siriana 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BS - Bahamas 1
BY - Bielorussia 1
CH - Svizzera 1
CU - Cuba 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GT - Guatemala 1
HU - Ungheria 1
KH - Cambogia 1
LB - Libano 1
LV - Lettonia 1
ML - Mali 1
MU - Mauritius 1
NI - Nicaragua 1
PA - Panama 1
TV - Tuvalu 1
Totale 8.840
Città #
Singapore 1.031
Hong Kong 533
Dallas 504
Ashburn 398
Shanghai 286
Hefei 227
Milan 195
Beijing 180
New York 129
Los Angeles 115
Munich 52
Moscow 51
Rome 51
São Paulo 51
Ho Chi Minh City 50
Nuremberg 48
Boardman 46
Seattle 46
Hanoi 39
Turku 39
Washington 39
Montreal 38
Tokyo 38
Chennai 36
Santa Clara 34
Brooklyn 33
Denver 32
Orem 32
Warsaw 31
Mexico City 30
Helsinki 28
London 28
Johannesburg 27
Amsterdam 26
Atlanta 26
Poplar 25
Phoenix 22
Stockholm 22
Belo Horizonte 20
Canberra 20
Houston 20
Rio de Janeiro 19
Toronto 19
Valencia 19
Vienna 19
Chicago 17
Assago 16
Cesano Boscone 16
Lappeenranta 16
Ankara 15
Guangzhou 15
Lawrence 15
Princeton 15
San Francisco 15
Bologna 14
Council Bluffs 14
Falkenstein 13
Frankfurt am Main 12
Manchester 12
Querétaro 12
Sydney 12
Florence 11
Bang Kruai 10
Biên Hòa 10
Naples 10
St Louis 10
Campinas 9
Curitiba 9
Haiphong 9
Hangzhou 9
Mumbai 9
Salvador 9
Bari 8
Brasília 8
Brescia 8
City of London 8
Fortaleza 8
Pisa 8
Quito 8
Rabat 8
Aracaju 7
Boston 7
Buffalo 7
Changsha 7
Porto Alegre 7
Ribeirão Preto 7
Riyadh 7
Tashkent 7
Tianjin 7
Vancouver 7
Asunción 6
Caxias do Sul 6
Charlotte 6
Dhaka 6
Raleigh 6
San Jose 6
Santo André 6
Secaucus 6
Shenzhen 6
Turin 6
Totale 5.282
Nome #
Contrast-Enhanced Mammography versus Breast Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis 130
[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration 126
Early regression index (ERI) on MR images as response predictor in esophageal cancer treated with neoadjuvant chemo-radiotherapy: interim analysis of the prospective ESCAPE trial 113
Data-Driven Motion Correction of 11C-Methionine PET Images on a Cohort of Pediatric Patients With Brain Tumor in a PET/MRI Study 113
EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems 112
[18F]FDG-PET/CT Texture Analysis in “Hot” Thyroid Nodules: Results of the validation Cohort 93
Prognostic Value of Metabolic Imaging Data of 11C-choline PET/CT in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma 91
Random forest analysis to predict Disease-Free Survival using FDG-PET and CT in Lung Cancer 89
Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study 82
Deep learning in Nuclear Medicine—focus on CNN-based approaches for PET/CT and PET/MR: where do we stand? 76
A Multimodal Protocol Combining 99mTc-Tilmanocept with Indocyanine Green Fluorescence Lympho-Angiography for Sentinel Lymph Node Biopsy in Early-Stage Oral Cancer: A Case Series. 76
Malignant pleural effusion (MPE) characterized with 11C-Methionine PET/CT before and after talc pleurodesis: interim evaluation of a prospective clinical trial 76
Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial 75
[18F]FDG PET/CT in Large Vessel Vasculitis: The Impact of Expertise and Confounders on Image Analysis 75
Virtual Biopsy for Diagnosis of Chemotherapy-Associated Liver Injuries and Steatohepatitis: A Combined Radiomic and Clinical Model in Patients with Colorectal Liver Metastases 72
Systematic Review and Metanalysis on the Role of Prostate-Specific Membrane Antigen Positron Emission Tomography/Magnetic Resonance Imaging for Intraprostatic Tumour Assessment 72
Computed tomography (CT)-derived radiomic features differentiate prevascular mediastinum masses as thymic neoplasms versus lymphomas 72
Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters 71
ALBI grade for outcome prediction in patients affected by hepatocellular carcinoma treated with transarterial radioembolization 71
Allogeneic Stem Cell Transplantation (Allo-SCT) after Treatment with Programmed Cell Death-1 (PD-1) Checkpoint Inhibitors for Relapsed/Refractory Classic Hodgkin Lymphoma (R/R cHL) Is Associated with an Unprecedented Low Relapse Rate 71
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 69
Senna intoxication as a cause of extrapontine myelinolysis mimicking rapidly progressive dementia: a case description 69
Baseline circulating tumour DNA and interim PET predict response in relapsed/refractory classical Hodgkin lymphoma 69
[F-18]FDG PET/CT in non-union: improving the diagnostic performances by using both PET and CT criteria 69
48P The relationship among bowel FDG-PET uptake, pathological complete response, and the influence of eating and exercise habits in breast cancer patients undergoing neoadjuvant chemotherapy 65
Advanced Imaging Supports the Mechanistic Role of Autoimmunity and Plaque Rupture in COVID-19 Heart Involvement 65
Single-Center Retrospective Study Comparing Double Vein Embolization via a Trans-Jugular Approach with Liver Venous Deprivation via a Trans-Hepatic Approach 65
Absorbed dose from daily routine practice in an 18F-FDG producing radiopharmacy 63
Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions 63
Preoperative assessment of lymph nodal metastases with [68Ga]Ga-DOTATOC PET radiomics for improved surgical planning in well-differentiated pancreatic neuroendocrine tumours 63
Imaging-Based Prediction of Molecular Therapy Targets in NSCLC by Radiogenomics and AI Approaches: A Systematic Review 62
Imaging in Gastroparesis: Exploring Innovative Diagnostic Approaches, Symptoms, and Treatment 62
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients 62
Cutting back on overdiagnosis – Occam’s Razor and unspecific bone uptakes in PSMA PET 62
The five “W”s and “How” of Targeted Alpha Therapy: Why? Who? What? Where? When? and How? 61
State-of-the-art of FAPI-PET imaging: a systematic review and meta-analysis 61
Baseline FDG-PET/CT Radiomics to Predict Outcome in Lung Cancer Patients Treated with Surgery 60
Challenging the significance of SUV-based parameters in a large-scale retrospective study on lung lesions 59
18F-FDG PET and CT scan in the pre-operative evaluation of colorectal liver metastases treated with chemotherapy 59
Advancing EJNMMI: continuing success and next developments 58
Radioembolization for Hepatocellular Carcinoma: a Comparison on Dual-phase Cone-beam CT, Contrast-enhanced CT (CECT) and 99mTc-macroaggregated albumin-SPECT/CT in predicting final distribution volumes and dosimetry of the post-embolization 90Y PET/CT 58
PSMA PET in brain metastases: navigating diagnostic challenges– a thorough exploration 57
Predictors of PSMA PET Positivity: Analysis in a Selected Cohort of Biochemical Recurrence Prostate Cancer Patients after Radical Prostatectomy 56
A virtual biopsy of liver parenchyma to predict the outcome of liver resection 56
Prevention of Orbitopathy by Oral or Intravenous Steroid Prophylaxis in Short Duration Graves' Disease Patients Undergoing Radioiodine Ablation: A Prospective Randomized Control Trial Study 54
The Challenge of External Generalisability: Insights from the Bicentric Validation of a [68Ga]Ga-PSMA-11 PET Based Radiomics Signature for Primary Prostate Cancer Characterisation Using Histopathology as Reference 53
68GA-PSMA PET/CT FOR PRIMARY DIAGNOSIS OF PROSTATE CANCER IN MEN WITH CONTRAINDICATIONS TO OR NEGATIVE MRI: A PROSPECTIVE OBSERVATIONAL STUDY 53
Mapping brain metabolism, connectivity and neurotransmitters topography in early and late onset dementia with lewy bodies 52
Towards clinical application of image mining: a systematic review on artificial intelligence and radiomics 51
The Role of PET Imaging in the Differential Diagnosis between Radiation Necrosis and Recurrent Disease in Irradiated Adult-Type Diffuse Gliomas: A Systematic Review 50
The potential role of osteoporosis in unspecific [18F]PSMA-1007 bone uptake 50
Enhancing NSCLC Histological Subtype Classification: A Federated Learning Approach Using Triplet Loss 49
Match Point: Nuclear Medicine Imaging for Recurrent Thyroid Cancer in TENIS Syndrome—Systematic Review and Meta-Analysis 48
Smaller is better? Compact vs. Conventional gamma camera for sentinel lymph node localization in patients with breast cancer 48
The complementary role of PSMA expression and [18F]FDG PET/CT in predicting thyroid cancer outcome: from black and white to shades of gray, in the era of precision oncology 48
Complete remission of follicular lymphoma after SARS-CoV-2 infection: from the "flare phenomenon" to the "abscopal effect" 47
Myocardial involvement in systemic sclerosis 47
Baseline Radiomic CT Features Differentiate Mediastinal Masses As Thymic Neoplasms Or Lymphomas 46
The future of transpathology 46
Identifying critical steps towards improved access to innovation in cancer care: a European CanCer Organisation position paper 45
Individual cerebral metabolic deficits in Alzheimer's disease and amnestic mild cognitive impairment: an FDG PET study 45
Minimally-invasive treatments for benign thyroid nodules: a Delphi-based consensus statement from the Italian minimally-invasive treatments of the thyroid (MITT) group 45
Vasculitis changes in COVID-19 survivors with persistent symptoms: an [18F]FDG-PET/CT study 44
PET/CT-based radiomics of mass-forming intrahepatic cholangiocarcinoma improves prediction of pathology data and survival 44
C-11-Methionine uptake in secondary brain epilepsy 44
Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis 44
EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees 44
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study 44
Convolutional Neural Networks Promising in Lung Cancer T-Parameter Assessment on Baseline FDG-PET/CT 43
A reflection on journal rankings 43
Application of Convolutional Neural Networks is promising in the definition of T-stage in lung cancer 43
arallel comparison of 68Ga-Prostate Specific Membrane Antigen PET-CT and PRIMUS in primary prostate cancer diagnosis 42
Biological characterization of renal masses using immuno-PET 42
Role of 11C Methionine Positron Emission Tomography (11CMETPET) for Surgery and Radiation Therapy Planning in Newly Diagnosed Glioblastoma Patients Enrolled into a Phase II Clinical Study 42
Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study 42
The diagnostic and prognostic value of tau-PET in amnestic MCI with different FDG-PET subtypes 41
Radiomics and gene expression profile to characterise the disease and predict outcome in patients with lung cancer 41
Key elements of preparedness for pandemic coronavirus disease 2019 (COVID-19) in nuclear medicine units 41
Radiomics of Intrahepatic Cholangiocarcinoma and Peritumoral Tissue Predicts Postoperative Survival: Development of a CT-Based Clinical-Radiomic Model 40
I-131/I-123-Metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging 40
Radiomics of Liver Metastases: A Systematic Review 40
Ga-68-PSMA PET/CT for primary diagnosis of prostate cancer in men with contraindications to or negative mpMRI 40
Explainable domain transfer of distant supervised cancer subtyping model via imaging-based rules extraction 39
Hodgkin lymphoma and imaging in the era of anti-PD-1/PD-L1 therapy 39
Hybrid PET/MRI in Infection and Inflammation: An Update About the Latest Available Literature Evidence 39
Intrahepatic cholangiocellular carcinoma with radiological enhancement patterns mimicking hepatocellular carcinoma 39
Emergency endovascular treatments for delayed hemorrhage after pancreaticobiliary surgery: indications, outcomes, and follow-up of a retrospective cohort 39
Short-term health-related quality of life, physical function and psychological consequences of severe COVID-19 38
Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study 38
EANM/EARL FDG-PET/CT accreditation - summary results from the first 150 accredited imaging sites 38
Preoperative [11C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas 38
Advances in Diagnostic Imaging 38
Consensus on molecular imaging and theranostics in prostate cancer 38
Imaging Correlates between Headache and Breast Cancer: An [18F]FDG PET Study 38
External Validation of Nomograms for the Identification of Pelvic Nodal Dissection Candidates Among Prostate Cancer Patients with Negative Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography 37
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results 37
Recurrence-specific supervised graph clustering for subtyping Hodgkin Lymphoma radiomic phenotypes 37
HCC Radioembolization with Yttrium-90 Polymer Beads (SIR-Spheres):Tc-99m-MAA SPECT/CT based dosimetry correlation with survival and tumor response 37
The Role of 99mTc-Sestamibi Single-photon Emission Computed Tomography/Computed Tomography in the Diagnostic Pathway for Renal Masses: A Systematic Review and Meta-analysis 37
A Comprehensive Systematic Review and Meta-analysis of the Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Diagnosis and Primary Staging before Definitive Treatment 37
Totale 5.653
Categoria #
all - tutte 58.488
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.488


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 2 0 0 0 0 0 0
2021/20225 0 0 0 5 0 0 0 0 0 0 0 0
2022/2023466 34 16 7 0 0 5 2 6 8 52 324 12
2023/20241.042 16 78 110 70 81 164 63 119 61 76 54 150
2024/20253.042 296 93 38 94 157 297 347 269 522 431 252 246
2025/20264.873 798 751 668 1.368 954 334 0 0 0 0 0 0
Totale 9.442